Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 4, 2014, Pages

  Smith, Joshua A ^a   Jay Stallons, L ^a   Schnellmann, Rick G ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; EGFR; Hexokinase; Lipopolysaccharide; Pentose phosphate pathway

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEXOKINASE; LACTIC ACID; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PYRUVIC ACID;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOLYSIS; KIDNEY CORTEX; MALE; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; EGFR; HEXOKINASE; LIPOPOLYSACCHARIDE; PENTOSE PHOSPHATE PATHWAY;

ACUTE KIDNEY INJURY; ANIMALS; ENZYME ACTIVATION; GLUCOSEPHOSPHATE DEHYDROGENASE; GLYCOLYSIS; HETEROCYCLIC COMPOUNDS, 3-RING; HEXOKINASE; KIDNEY CORTEX; LIPOPOLYSACCHARIDES; MALE; MICE; PENTOSE PHOSPHATE PATHWAY; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84906062856     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00271.2014     Document Type: Article

References (75)

1. Ardawi MS, Khoja SM, Newsholme EA. Metabolic regulation of renal gluconeogenesis in response to sepsis in the rat. Clin Sci 79: 483-490, 1990.
2. Arora KK, Pedersen PL. Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J Biol Chem 263: 17422-17428, 1988.
3. Arrington DD, Van Vleet TR, Schnellmann RG. Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction. Am J Physiol Cell Physiol 291: C1159-C1171, 2006.
4. Ash SR, Cuppage FE. Shift toward anaerobic glycolysis in the regenerating rat kidney. Am J Pathol 60: 385-402, 1970.
5. Bagnasco S, Good D, Balaban R, Burg M. Lactate production in isolated segments of the rat nephron. Am J Physiol Renal Fluid Electrolyte Physiol 248: F522-F526, 1985.
6. Bellomo R, Kellum JA, Pinsky MR. Transvisceral lactate fluxes during early endotoxemia. Chest 110: 198-204, 1996.
7. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 380: 756-766, 2012.
8. BeltrandelRio H, Wilson JE. Hexokinase of rat brain mitochondria: relative importance of adenylate kinase and oxidative phosphorylation as sources of substrate ATP, and interaction with intramitochondrial compartments of ATP and ADP. Arch Biochem Biophys 286: 183-194, 1991.
9. Bryson JM, Coy PE, Gottlob K, Hay N, Robey RB. Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J Biol Chem 277: 11392-11400, 2002.
10. 31P NMR spectroscopy. Am J Physiol Endocrinol Metab 280: E598-E607, 2001.
11. Chen J, Shetty S, Zhang P, Gao R, Hu Y, Wang S, Li Z, Fu J. Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. Toxicol Appl Pharmacol 277: 118-123, 2014.
12. Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR, Tortora G. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer Res 6: 2053-2063, 2000.
13. Devalaraja-Narashimha K, Padanilam BJ. PARP-1 inhibits glycolysis in ischemic kidneys. J Am Soc Nephrol 20: 95-103, 2009.
14. Dickman KG, Mandel LJ. Differential effects of respiratory inhibitors on glycolysis in proximal tubules. Am J Physiol Renal Fluid Electrolyte Physiol 258: F1608-F1615, 1990.
15. Finzi L, Shao MX, Paye F, Housset C, Nadel JA. Lipopolysaccharide initiates a positive feedback of epidermal growth factor receptor signaling by prostaglandin E2 in human biliary carcinoma cells. J Immunol 182: 2269-2276, 2009.
16. Funk JA, Schnellmann RG. Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am J Physiol Renal Physiol 302: F853-F864, 2012.
17. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15: 1406-1418, 2001.
18. Grossbard L, Schimke RT. Multiple hexokinases of rat tissues. Purification and comparison of soluble forms. J Biol Chem 241: 3546-3560, 1966.
19. Guder WG, Ross BD. Enzyme distribution along the nephron. Kidney Int 26: 101-111, 1984.
20. Gullans SR, Brazy PC, Soltoff SP, Dennis VW, Mandel LJ. Metabolic inhibitors: effects on metabolism and transport in the proximal tubule. Am J Physiol Renal Fluid Electrolyte Physiol 243: F133-F140, 1982.
21. He S, Liu N, Bayliss G, Zhuang S. EGFR activity is required for renal tubular cell dedifferentiation and proliferation in a murine model of folic acid-induced acute kidney injury. Am J Physiol Renal Physiol 304: F356-F366, 2013.
22. Heemskerk AE, Huisman E, van Lambalgen AA, van den Bos GC, Hennekes M, Thijs LG, Tangelder GJ. Renal function and oxygen consumption during bacteraemia and endotoxaemia in rats. Nephrol Dial Transplant 12: 1586-1594, 1997.
23. Hirai H, Sootome H, Nakatsuru Y, Miyama K, Taguchi S, Tsujioka K, Ueno Y, Hatch H, Majumder PK, Pan BS, Kotani H. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther 9: 1956-1967, 2010.
24. Hsu D, Fukata M, Hernandez YG, Sotolongo JP, Goo T, Maki J, Hayes LA, Ungaro RC, Chen A, Breglio KJ, Xu R, Abreu MT. Toll-like receptor 4 differentially regulates epidermal growth factorrelated growth factors in response to intestinal mucosal injury. Lab Invest 90: 1295-1305, 2010.
25. Irimia JM, Rovira J, Nielsen JN, Guerrero M, Wojtaszewski JF, Cusso R. Hexokinase 2, glycogen synthase and phosphorylase play a key role in muscle glycogen supercompensation. PloS One 7: e42453, 2012.
26. Kalakeche R, Hato T, Rhodes G, Dunn KW, El-Achkar TM, Plotkin Z, Sandoval RM, Dagher PC. Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment. J Am Soc Nephrol 22: 1505-1516, 2011.
27. Kelly KJ, Molitoris BA. Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol 20: 4-19, 2000.
28. Kuper C, Beck FX, Neuhofer W. Toll-like receptor 4 activates NF-κB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells. Am J Physiol Renal Physiol 302: F38-F46, 2012.
29. Legrand M, Almac E, Mik EG, Johannes T, Kandil A, Bezemer R, Payen D, Ince C. L-NIL prevents renal microvascular hypoxia and increase of renal oxygen consumption after ischemia-reperfusion in rats. Am J Physiol Renal Physiol 296: F1109-F1117, 2009.
30. Legrand M, Bezemer R, Kandil A, Demirci C, Payen D, Ince C. The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med 37: 1534-1542, 2011.
31. Li XJ, Zhang GX, Sun N, Sun Y, Yang LZ, Du YJ. Protective effects of erythropoietin on endotoxin-related organ injury in rats. J Huazhong Univ Sci Technolog Med Sci 33: 680-686, 2013.
32. Liaudet L, Fishman D, Markert M, Perret C, Feihl F. L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia. Am J Respir Crit Care Med 155: 1643-1648, 1997.
33. Liu N, Guo JK, Pang M, Tolbert E, Ponnusamy M, Gong R, Bayliss G, Dworkin LD, Yan H, Zhuang S. Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis. J Am Soc Nephrol 23: 854-867, 2012.
34. McElroy SJ, Hobbs S, Kallen M, Tejera N, Rosen MJ, Grishin A, Matta P, Schneider C, Upperman J, Ford H, Polk DB, Weitkamp JH. Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. PloS One 7: e38373, 2012.
35. Miyamoto S, Murphy AN, Brown JH. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ 15: 521-529, 2008.
36. Nowak G, Schnellmann RG. Integrative effects of EGF on metabolism and proliferation in renal proximal tubular cells. Am J Physiol Cell Physiol 269: C1317-C1325, 1995.
37. Osawa H, Printz RL, Whitesell RR, Granner DK. Regulation of hexokinase II gene transcription and glucose phosphorylation by catecholamines, cyclic AMP, and insulin. Diabetes 44: 1426-1432, 1995.
38. Pastorino JG, Hoek JB. Regulation of hexokinase binding to VDAC. J Bioenerg Biomembr 40: 171-182, 2008.
39. Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 277: 7610-7618, 2002.
40. Patil NK, Parajuli N, Macmillan-Crow LA, Mayeux PR. Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria targeted antioxidant mitigates injury. Am J Physiol Renal Physiol 306: F734-F743, 2014.
41. Preller A, Wilson CA, Quiroga-Roger D, Ureta T. Hexokinase and not glycogen synthase controls the flux through the glycogen synthesis pathway in frog oocytes. FEBS Lett 587: 2825-2831, 2013.
42. Preller A, Wilson JE. Localization of the type III isozyme of hexokinase at the nuclear periphery. Arch Biochem Biophys 294: 482-492, 1992.
43. Riddle SR, Ahmad A, Ahmad S, Deeb SS, Malkki M, Schneider BK, Allen CB, White CW. Hypoxia induces hexokinase II gene expression in human lung cell line A549. Am J Physiol Lung Cell Mol Physiol 278: L407-L416, 2000.
44. Roberts DJ, Tan-Sah VP, Smith JM, Miyamoto S. Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J Biol Chem 288: 23798-23806, 2013.
45. Robey RB, Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25: 4683-4696, 2006.
46. Robey RB, Ma J, Santos AV, Noboa OA, Coy PE, Bryson JM. Regulation of mesangial cell hexokinase activity and expression by heparin-binding epidermal growth factor-like growth factor: epidermal growth factors and phorbol esters increase glucose metabolism via a common mechanism involving classic mitogen-activated protein kinase pathway activation and induction of hexokinase II expression. J Biol Chem 277: 14370-14378, 2002.
47. Schley G, Klanke B, Schodel J, Forstreuter F, Shukla D, Kurtz A, Amann K, Wiesener MS, Rosen S, Eckardt KU, Maxwell PH, Willam C. Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury. J Am Soc Nephrol 22: 2004-2015, 2011.
48. Schrier RW, Wang W. Acute renal failure and sepsis. New Engl J Med 351: 159-169, 2004.
49. Shimahara Y, Kono Y, Tanaka J, Ozawa K, Sato T, Jones RT, Cowley RA, Trump BF. Pathophysiology of acute renal failure following living Escherichia coli injection in rats: high-energy metabolism and renal functions. Circ Shock 21: 197-205, 1987.
50. Shulman RG, Bloch G, Rothman DL. In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis. Proc Natl Acad Sci USA 92: 8535-8542, 1995.
51. Soltoff SP. ATP and the regulation of renal cell function. Annu Rev Physiol 48: 9-31, 1986.
52. Stallons LJ, Funk JA, Schnellmann RG. Mitochondrial homeostasis in acute organ failure. Curr Pathobiol Rep 1: 2013.
53. Stanton RC. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64: 362-369, 2012.
54. Stanton RC, Seifter JL. Epidermal growth factor rapidly activates the hexose monophosphate shunt in kidney cells. Am J Physiol Cell Physiol 254: C267-C271, 1988.
55. Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, Zhao Z, Ganger M, Tow CY, Seshan SV. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 22: 1041-1052, 2011.
56. Takahashi K, Mizukami H, Kamata K, Inaba W, Kato N, Hibi C, Yagihashi S. Amelioration of acute kidney injury in lipopolysaccharideinduced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat. PloS One 7: e30134, 2012.
57. Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, Jarman S, Efimov IR, Janks DL, Srivastava A, Bhayani SB, Drewry A, Swanson PE, Hotchkiss RS. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med 187: 509-517, 2013.
58. Taneja N, Coy PE, Lee I, Bryson JM, Robey RB. Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance. Am J Physiol Cell Physiol 287: C548-C557, 2004.
59. Tang J, Liu N, Zhuang S. Role of epidermal growth factor receptor in acute and chronic kidney injury. Kidney Int 83: 804-810, 2013.
60. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. New Engl J Med 334: 1448-1460, 1996.
61. Thuringer D, Hammann A, Benikhlef N, Fourmaux E, Bouchot A, Wettstein G, Solary E, Garrido C. Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells. J Biol Chem 286: 3418-3428, 2011.
62. Tran M, Tam D, Bardia A, Bhasin M, Rowe GC, Kher A, Zsengeller ZK, Akhavan-Sharif MR, Khankin EV, Saintgeniez M, David S, Burstein D, Karumanchi SA, Stillman IE, Arany Z, Parikh SM. PGC-1alpha promotes recovery after acute kidney injury during systemic inflammation in mice. J Clin Invest 121: 4003-4014, 2011.
63. Trump BF, Valigorsky JM, Jones RT, Mergner WJ, Garcia JH, Cowley RA. The application of electron microscopy and cellular biochemistry to the autopsy. Observations on cellular changes in human shock. Human Pathol 6: 499-516, 1975.
64. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Beginning, and ending supportive therapy for the kidney. I. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813-818, 2005.
65. Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 3: 844-861, 2008.
66. Wang Z, Holthoff JH, Seely KA, Pathak E, Spencer HJ 3rd, Gokden N, Mayeux PR. Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury. Am J Pathol 180: 505-516, 2012.
67. Wills LP, Trager RE, Beeson GC, Lindsey CC, Peterson YK, Beeson CC, Schnellmann RG. The beta2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. J Pharmacol Exp Ther 342: 106-118, 2012.
68. Wilson JE. Hexokinases. Rev Physiol Biochem Pharmacol 126: 65-198, 1995.
69. Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 206: 2049-2057, 2003.
70. Wirthensohn G, Guder WG. Renal substrate metabolism. Physiol Rev 66: 469-497, 1986.
71. Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, Mayeux PR. Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol 292: F261-F268, 2007.
72. Wu X, Guo R, Wang Y, Cunningham PN. The role of ICAM-1 in endotoxin-induced acute renal failure. Am J Physiol Renal Physiol 293: F1262-F1271, 2007.
73. Xu Y, Zhang Z, Hu J, Stillman IE, Leopold JA, Handy DE, Loscalzo J, Stanton RC. Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria. FASEB J 24: 609-616, 2010.
74. Yap TA, Yan L, Patnaik A, Fearen I, Olmos D, Papadopoulos K, Baird RD, Delgado L, Taylor A, Lupinacci L, Riisnaes R, Pope LL, Heaton SP, Thomas G, Garrett MD, Sullivan DM, de Bono JS, Tolcher AW. First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors. J Clin Oncol 29: 4688-4695, 2011.
75. Zager RA, Johnson AC, Becker K. Renal cortical pyruvate depletion during AKI. J Am Soc Nephrol 25: 998-1012, 2014.